Stichting OLVG — Clinical Trial Site

82 Registered trials

38 Currently recruiting

Organisation

Stichting OLVG

Location

Amsterdam, Netherlands

Identifier

ORG-100029947

Address

Oosterpark 9, 1091 AC, Netherlands

Departments

#1703: Cardiology
#2901:Cardiology
#3724: Cardiology
2619:Cardiology
3724: Cardiology
Anaesthesia
Anesthesiology
Cardiology
Cardiology Research
Department of Gastroenterology & hepatology
Department of Surgery
Gastroenterology
Gynecology and obstetrics
Hematologie Oncologie
Hematology
Hematology-Oncology
Intensive Care
Internal Disease
Internal Medicine
Internal medicine / Oncology
Interne geneeskunde
MDL
Medical Oncology
Medical Oncology and Hematology
N/A
NA
Neurologie
Neurology
Obstrics & Gynecology
Oncology
Ophthalmology
Orthopedic surgery
orthopedics
Psychiatry
Pulmonology
Secretariaat cardiologie research N3.59
Surgery
Surgery HPB and colorectal

Clinical trials at this site (82)

Search interface

Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-lin… Ended

2024-516202-39-00 Metastatic breast cancer 4 2013-10-10
A Study to Understand the ability and safety of GDC-8264 in Preventing kidney Injury and Major Adverse Kidney Events following Heart Surgery Ended

2024-513125-23-00 Patients with moderate to high risk for cardiac surgery 4 2025-02-28
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A multicenter, randomized, open-label, blinded endpoint evaluation, phase 3 study comparing the effect of abelacimab relative to apixaban on… Ended

2023-509569-19-00 venous thromboembolism (VTE) 10 2022-08-10
A study to learn how well the treatment combination of finerenone and empagliflozin works and how safe it is compared to each treatment alon… Ended

2023-506981-30-00 Chronic kidney disease in type 2 diabetes mellitus 4 2022-05-25
A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of IV FDY-5301 in patients with a myocardial infarction (STEMI) Ended

2024-514372-40-00 Anterior ST-Elevation Myocardial Infarction 5 2022-04-12
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
GIVE trial (Gazyvaro In combination with VEnetoclax in Elderly CLL) Ended

2024-511048-22-00 Chronic lymphocytic leukemia 4 2016-10-27
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15